Back to VoiceAmerica Media

Switch Show

The Ellis Martin Report

Home
Episodes

Season 24 1 All Episodes 244
About
Reviews

All Reviews Leave a Review

Rate on Apple Podcasts

Rate on Spotify
Contact

Search

Spotify All Players

Spotify All Players

Search

Nov. 7, 2018

Rob McEwen, Brent Cook, Cypress Development, Matinas Biopharma

Rob McEwen, Brent Cook, Cypress Development, Matinas Biopharma

Rob McEwen, Brent Cook, Cypress Development, Matinas Biopharma

The Ellis Martin Report

Rob McEwen, Brent Cook, Cypress Development, Matinas Biopharma

Apple Podcasts podcast player icon

Spotify podcast player icon

Apple Podcasts podcast player icon

Spotify podcast player icon

Show Notes

The Ellis Martin Report

Each week the Ellis Martin Report brings you potential investment opportunities and analysis of financial markets including a variety of commodities. If you’re truly seeking to possibly buy low and sell high, listen as Ellis interviews public companies that in many cases are just beginning to get their success-based stories out to the public. If geopolitics is your area of interest, learn how global tensions and market stresses can affect your money. Opportunity exists, especially in volatility. Trade short or trade long based on news….or sit on the sidelines collecting information until the time comes where you are well positioned to act. Invest at your own risk. Ellis Martin is a veteran broadcast journalist, not a financial adviser. We make no specific recommendation for investment on this program.brbr
Note: Companies reviewed on the Ellis Martin Report in most cases are paid sponsors. Ellis Martin may also be a shareholder of companies mentioned.

Episodes
About

Reviews
Contact

© 2026 VoiceAmerica Media